Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Refractory metastatic Crohn's disease responsive to ustekinumab dose intensification.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Refractory metastatic Crohn's disease responsive to ustekinumab dose intensification.
Refractory metastatic Crohn's disease responsive to ustekinumab dose intensification. JAAD Case Rep. 2023 Feb; 32:65-67.
View in:
PubMed
authors with profiles
Mark Hoffman
Arlene M. Ruiz De Luzuriaga